Tag: venous stenting

VIRTUS 12-month outcomes presented at LINC: Vici stent meets primary endpoints

New 12-month data from the VIRTUS trial demonstrates that patients who were treated with the Vici Venous Stent system (Boston Scientific) for iliac and femoral...
Michael Dake

VERNACULAR trial 12-month data show successful use of Venovo stent in...

The 12-month results from the VERNACULAR trial have shown that the Venovo venous stent (BD Interventional) is successful when deployed in obstructive iliac and...

Worse outcomes in peripartum compared to non-pregnant women stented for DVT

Peripartum women with deep vein thrombosis (DVT) treated with catheter-directed thrombolysis and venous stenting had significantly increased rates of reintervention and loss of stent patency...

New intravascular ultrasound-based scoring system may predict future venous stent failure

To accompany the growing importance of intravascular ultrasound (IVUS) as an adjuvant diagnostic tool when treating deep venous disease, a study sought to create...

Reviewing five years of deep venous stenting: What comes next?

For many venous specialists, dedicated venous stents represent the future—and the promise of an ideal venous stent on the horizon is a central topic...

Use of IVUS to optimise outcomes in venous stenting

Intravascular ultrasound (IVUS) imaging technology provides the current gold standard technique for detection and characterisation of venous disease, Erin Murphy writes. In this article,...
UIP 2018

UIP audience votes against stenting as standard for deep vein obstruction

The deep venous world is wrestling with the question: To stent or not to stent. While the availability of new specialised venous stents is...

First-in-man usage of blueflow venous stent

Following the announcement of receiving the CE mark in early 2018, ab medica has now reported the first-in man usage of its blueflow Venous...

One-year data from venous stent registry “promising”

Efficacy data from the Arnsberg Registry at 12 months are promising, with high primary patency rates for a dedicated venous stent. Presenting the data at...

IDE study to evaluate Abre Venous Self-Expanding Stent in patients with...

Medtronic has announced the initiation of its investigational device exemption (IDE) study for the Abre venous self-expanding stent system. The ABRE IDE Study will...

Identifying standard practices of antithrombotic therapy post-venous stenting

Venous stenting has evolved over the last 15 years, quickly becoming an established procedure, with Class II recommendations from the American Heart Association and...

New research indicates that stenting below the inguinal ligament does not...

Endovascular treatment of iliocaval and infrainguinal post-thrombotic venous obstruction results do not appear to be adversely affected by extension of the iliac vein stents...
Adam Gwozdz

Decision-making in the choice of anticoagulants following deep venous stenting

Deep venous stenting has become increasingly used to treat patients with pathological obstruction of venous return in the femoro-iliocaval venous segment following the development of new...